Delivery Order SPE2DB22D1017-SPE2DB25FF4CS

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,793.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567110760 - DROXIDOPA 200 MG CAPSULE 90S, with an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $70,711.90 Firm Fixed Price Delivery Order contract is for the supply of DROXIDOPA 100 MG CAPSULE 90S, a specialty medication, with a completion date of May 23, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $15,230.71 and is a delivery order for the supply of 4566601202 - DROXIDOPA 100 MG CAPSULE 90S. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,814.38 delivery order contract is for the supply of 4,563,338,296 droxidopa 100 mg capsules. The contract has an ultimate completion date of January 17, 2024 and is a firm-fixed price contract type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $60,045.24 and is for the delivery of DROXIDOPA 100 MG CAPSULE 90S, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 22, 2023. It is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award, valued at $16,195.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566803424 DROXIDOPA 300 MG CAPSULE 90S, a specialty medication, with a completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,125.98 firm fixed-price delivery order is for the supply of DROXIDOPA 100 MG CAPSULE 90S, a specialty medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 36,000 units of a 100-count capsule product under a Firm Fixed Price Delivery Order contract valued at $8,454.64. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense that provides medical supplies to military healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,837.05 firm fixed-price delivery order is for the provision of various pharmaceutical products and medical supplies to support military healthcare programs. The contract has an ultimate completion date of February 18, 2025. Amerisourcebergen holds a significant $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $6,776.80, is a delivery order placed by the Defense Logistics Agency (DLA) to supply 4,564,666,798 units of the prescription medication droxidopa 200 mg capsule in quantities of 90s. The award has no set-aside designation and is a firm fixed-price contract. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF4CS
    Delivery Order

This federal contract award, valued at $8,121.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of 4567074635 DROXIDOPA 100 MG CAPSULE 90S, with a period of performance through January 29, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

This particular contract award does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 10:26 AM